Privia Health Group, Inc. - Common Stock (PRVA)

Privia lifts 2026 outlook as it exits Montana and adds American Choice.

Healthcare tech company Privia Health Group (NASDAQ:PRVA) announced better-than-expected revenue in Q3 2026, with revenue up 13.2% year on year to $657 milli...

Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be reporting earnings this Thursday before market hours. Here’s what to look for. Privia Healt...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market va...

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o...

Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a co...

Looking back on healthcare technology for providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Privia Health (NASDAQ...

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

Privia Health has been treading water for the past six months, recording a small loss of 1.7% while holding steady at $21.63. The stock also fell short of th...

Net income surged 237% while attributed lives grew 19%, signaling strong operational momentum.

Privia Health’s second quarter results were met with a negative market reaction as investors digested the company’s strong revenue growth alongside a materia...

Privia Health Group (NASDAQ:PRVA) reported second-quarter results marked by double-digit growth in implemented providers, attributed lives and practice collections, while adjusted EBITDA rose 29% from a year earlier. Management also raised its 2026 outlook for several financial measures following wh

Healthcare tech company Privia Health Group (NASDAQ:PRVA) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 21.4% year on year to $632.6 mi...

Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 21.4% year on y...

Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be reporting earnings this Thursday morning. Here’s what investors should know. Privia Health ...

Since January 2026, Privia Health has been in a holding pattern, posting a small return of 3.6% while floating around $24.97. Is there a buying opportunity i...

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg...

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...

This healthcare services provider, focused on value-based care, reported a notable insider sale amid a year of double-digit stock gains.

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...